Benitec Biopharma rings Nasdaq opening bell

Benitec Biopharma rang the Nasdaq opening bell Friday.

The company marked the start of trading at the exchange in celebration of its initial public offering.

The Nasdaq in Times Square, New York.
Getty Images
The Nasdaq in Times Square, New York.

Read MorePenumbra rings New York Stock Exchange bell

The company's CEO, Peter French, did the honors.

Based in Australia, Benitec develops treatments for Hepatitis B and C, lung cancer and other chronic and life- threatening diseases, according to the company's website.

Read MoreCRH Medical rings NYSE opening bell

Benitec trades on the Nasdaq under the ticker symbol BNTC.